
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $1B | -- | -- | $4.53 | -- |
07/22/2025 | Q2 | $1B | -- | -- | $4.78 | -- |
04/22/2025 | Q1 | $976.1M | $969.3M | $4.32 | $4.36 | -$0.04 |
02/18/2025 | Q4 | $1B | $1B | $3.84 | $3.63 | $0.22 |
10/22/2024 | Q3 | $1B | $1B | $4.11 | $4.00 | $0.11 |
07/24/2024 | Q2 | $1B | $1B | $4.91 | $4.17 | $0.74 |
05/01/2024 | Q1 | $987M | $977.8M | $4.32 | $3.31 | $1.01 |
02/21/2024 | Q4 | $1B | $1B | $1.38 | $3.05 | -$1.67 |
10/25/2023 | Q3 | -- | -- | -$2.34 | $3.73 | -$6.07 |
07/26/2023 | Q2 | -- | -- | $4.21 | $4.11 | $0.10 |
04/20/2023 | Q1 | -- | -- | $3.47 | $3.38 | $0.09 |
02/22/2023 | Q4 | -- | -- | $1.86 | $3.57 | -$1.71 |
10/26/2022 | Q3 | -- | -- | $3.34 | $3.41 | -$0.07 |
07/20/2022 | Q2 | -- | -- | $3.53 | $3.34 | $0.19 |
04/20/2022 | Q1 | -- | -- | $2.90 | $2.44 | $0.46 |
02/16/2022 | Q4 | -- | -- | $1.25 | $2.65 | -$1.40 |
10/20/2021 | Q3 | -- | -- | $2.40 | $2.47 | -$0.07 |
07/21/2021 | Q2 | -- | -- | $2.89 | $2.50 | $0.39 |
04/21/2021 | Q1 | -- | -- | $2.57 | $2.12 | $0.45 |
02/17/2021 | Q4 | -- | -- | $1.68 | $1.79 | -$0.11 |
10/21/2020 | Q3 | -- | -- | $1.84 | $1.72 | $0.12 |
07/22/2020 | Q2 | -- | -- | $1.06 | $1.44 | -$0.38 |
04/22/2020 | Q1 | -- | -- | $1.99 | $1.39 | $0.60 |
02/19/2020 | Q4 | -- | -- | $1.66 | $1.84 | -$0.18 |
10/24/2019 | Q3 | -- | -- | $1.85 | $2.30 | -$0.45 |
07/23/2019 | Q2 | -- | -- | $1.82 | $2.25 | -$0.43 |
04/23/2019 | Q1 | -- | -- | $1.64 | $1.74 | -$0.10 |
02/20/2019 | Q4 | -- | -- | $0.80 | $1.90 | -$1.10 |
10/23/2018 | Q3 | -- | -- | $0.20 | $1.78 | -$1.58 |
07/24/2018 | Q2 | -- | -- | $1.46 | $1.94 | -$0.48 |
04/19/2018 | Q1 | -- | -- | $1.72 | -- | -- |
02/21/2018 | Q4 | -- | -- | -$0.16 | -- | -- |
10/18/2017 | Q3 | -- | -- | $1.55 | -- | -- |
07/19/2017 | Q2 | -- | -- | $2.01 | -- | -- |
04/20/2017 | Q1 | -- | -- | $1.72 | -- | -- |
02/21/2017 | Q4 | -- | -- | $3.10 | -- | -- |
10/19/2016 | Q3 | -- | -- | $1.24 | -- | -- |
07/20/2016 | Q2 | -- | -- | $1.85 | -- | -- |
04/20/2016 | Q1 | -- | -- | $1.45 | -- | -- |
02/17/2016 | Q4 | -- | -- | -$1.34 | -- | -- |
10/21/2015 | Q3 | -- | -- | $0.52 | -- | -- |
Valmont Industries reported $969.3M worth of top line sales in its most recent quarter.
Valmont Industries announced earnings per share of $4.32 which represents a miss of analyst forecast a $4.36 per share.
Valmont Industries reported $291.1M that represents $14.41 per share over the last quarter.
Valmont Industries's earnings are forecast to grow from $17.19 per share to $16.97 per share next year representing an increase of 5.58%.
Valmont Industries's next earnings date is July 22, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.